Harrison Thomas L
SEC-identified person · CIK 1247340 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Antigenics INC /DE/ agend | Director | filed 2024–2026 |
| Acurx Pharmaceuticals, Inc. ACXP | Director | filed 2021–2026 |
| Advanced Flower Capital Inc. AFCG | Director | filed 2021–2025 |
| Zynerba Pharmaceuticals, Inc. ZYNE | Director | filed 2015–2018 |
| Fifth Street Asset Management Inc. FSAM | Director | filed 2014–2017 |
| PLx Pharma Inc. PLXP | Director | filed 2014–2017 |
| Rvue Holdings, Inc. RVUE | Director | filed 2013–2013 |
| Epocrates INC EPOC | Director | filed 2011–2013 |
| Morgans Hotel Group Co. MHGC | Director | filed 2006–2012 |
| Omnicom Group INC. [OMC] | Chrmn/CEO Drivers. Agency Serv | filed 2006–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.